-
Thukukile Zuma Resigns from ANC Johannesburg Leadership Amid Disciplinary Dispute
-
Russia Orders 100,000 Kometa Modules to Counter Ukrainian Electronic Warfare
-
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
-
Mahayuti-backed Rajesh Patil Elected Chairman of Gokul Dairy Amidst Political Deadlock
-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.
CTT Pharma - 813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
D.Kaufman--AMWN